Use our digital biomarkers to increase trial success
and drive drug commercialization
Translate Clinical Decision-Making Into Data Science
imvaria was founded in 2019 by a team of physician-engineers from Stanford and Google, seeking to empower clinicians and improve patient outcomes through the development and application of modern computer science techniques to complex and serious clinical problems. The company's Digital Biomarker Platform enables non-invasive diagnostic and therapeutic patient stratification via data science and machine learning.